Bonesupport Financial Statements From 2010 to 2024
| BOEUF Stock | USD 34.88 2.72 8.46% |
Check Bonesupport Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bonesupport Holding's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bonesupport financial statements analysis is a perfect complement when working with Bonesupport Holding Valuation or Volatility modules.
Bonesupport |
Bonesupport Holding AB Company Current Valuation Analysis
Bonesupport Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bonesupport Holding Current Valuation | 511.7 M |
Most of Bonesupport Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bonesupport Holding AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bonesupport Holding AB has a Current Valuation of 511.7 M. This is 96.44% lower than that of the Healthcare sector and 94.4% lower than that of the Medical Instruments & Supplies industry. The current valuation for all United States stocks is 96.92% higher than that of the company.
Bonesupport Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bonesupport Holding's current stock value. Our valuation model uses many indicators to compare Bonesupport Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bonesupport Holding competition to find correlations between indicators driving Bonesupport Holding's intrinsic value. More Info.Bonesupport Holding AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bonesupport Holding's earnings, one of the primary drivers of an investment's value.About Bonesupport Holding Financial Statements
Bonesupport Holding stakeholders use historical fundamental indicators, such as Bonesupport Holding's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bonesupport Holding investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bonesupport Holding's assets and liabilities are reflected in the revenues and expenses on Bonesupport Holding's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bonesupport Holding AB. Please read more on our technical analysis and fundamental analysis pages.
Bonesupport Holding AB , an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company was founded in 1999 and is headquartered in Lund, Sweden. Bonesupport Holding is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Bonesupport Pink Sheet
Bonesupport Holding financial ratios help investors to determine whether Bonesupport Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonesupport with respect to the benefits of owning Bonesupport Holding security.